← Open Payments lookup

JILLIAN TOAL: Open Payments

NPI 1619408358 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$561 in 32 payments from 11 companies in 2025. Trend: 2023 $36 · 2024 $27 · 2025 $561

Food & beverage: $561
CompanyPaymentsAmount
ABBVIE INC.9$135
Regeneron Healthcare Solutions, Inc.6$115
Lilly USA, LLC3$62
Janssen Biotech, Inc.3$61
Ardelyx, Inc.2$40
Takeda Pharmaceuticals U.S.A., Inc.2$37
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$35
Phathom Pharmaceuticals, Inc.2$30
Madrigal Pharmaceuticals1$17
Gilead Sciences, Inc.1$15

Products named: DUPIXENT, RINVOQ, OMVOH, TREMFYA, IBSRELA, XIFAXAN, VOQUEZNA, LINZESS.

Industry payments across PA — which companies pay providers there.